Thursday, February 12, 2015

Study: Only Two Thirds Of N2/N3 Breast Cancer Patients Receive PMRT

Radiation Therapy News (2/12, Semedo) reports on a study that found some may not follow guidelines from the National Comprehensive Cancer Network (NCCN) and the American Society of Clinical Oncology (ASCO) for post-mastectomy radiation therapy (PMRT), which is the standard of care for N2/N3 breast cancer treatment. The study, which examined records from a database carrying information on almost three million patients between 1998 and 2011, found that 82% of such patients were treated with chemotherapy, while only 65% were treated with PMRT. Lead author Quyen D. Chu, MD, MBA, FACS, said of the findings, “From this study, we could not tease out whether patients refuse treatment or there is a lack of awareness among women and physicians about the need for radiation therapy after mastectomy for locally advanced breast cancer.”

Read more here.


Categories: 2015, February, News, Research and CareNumber of views: 11101